Inovio Pharmaceuticals, Inc.
Inovio Pharma is a biotechnology company focused on the discovery, development, and commercialization of synthetic DNA-based vaccines and immunotherapies.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Inovio Pharmaceuticals' stock with a target price of $11.17, indicating strong potential.
Financial Health
Inovio Pharmaceuticals is struggling with low revenue and cash flow, indicating financial challenges.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring INO
Pediatric Vaccine Rollout
This carefully selected group of stocks represents companies positioned to benefit from the full FDA approval of COVID-19 vaccines for at-risk children. Our professional analysts have identified opportunities across the entire value chain, from vaccine manufacturers to healthcare providers and clinical research organizations.
Published: July 11, 2025
Explore BasketBuffett's Billions: The Philanthropy Effect
Warren Buffett just donated $6 billion to major foundations like the Gates Foundation. This curated list features companies in global health, agriculture, and education that are perfectly positioned to benefit from this massive philanthropic wave.
Published: July 1, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Clinical Catalysts Ahead
Pipeline trial readouts and regulatory steps can meaningfully move the share price; however, outcomes are binary and can be volatile.
Platform Innovation
The DNA electroporation approach is central to Inovio’s strategy and may offer differentiation, yet scientific and competitive risk remains.
Funding And Runway
Small‑cap status means funding rounds are possible and can dilute existing holders; monitor cash reports and partnership deals.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
